Detalhe da pesquisa
1.
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
Mult Scler
; 30(3): 381-395, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247113
2.
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.
Mult Scler
; 29(2): 236-247, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515394
3.
Untreated patients with multiple sclerosis: A study of French expert centers.
Eur J Neurol
; 28(6): 2026-2036, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650261
4.
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study.
Mult Scler
; 26(8): 936-944, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31148523
5.
Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data.
Epilepsia
; 59(9): 1727-1739, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30047129
6.
Adjunctive perampanel in refractory epilepsy: Experience at tertiary epilepsy care center in Tours.
Epilepsy Behav
; 61: 237-241, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27393930
7.
Long-term experience with perampanel in refractory epilepsy: Experience at tertiary epilepsy care center in Tours.
Epilepsy Behav
; 80: 376-377, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29396038
8.
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.
JAMA Netw Open
; 6(6): e2319766, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351881
9.
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 10(3)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810163
10.
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.
Neurology
; 100(12): e1296-e1308, 2023 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564207
11.
Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.
Neurol Neuroimmunol Neuroinflamm
; 10(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376096
12.
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal.
Neurotherapeutics
; 19(2): 476-490, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35217934
13.
High incidence of obstructive sleep apnea syndrome in patients with late-onset epilepsy.
Neurophysiol Clin
; 47(1): 55-61, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27988205